Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 39 studies | 48% ± 20% | |
| capillary endothelial cell | 15 studies | 42% ± 23% | |
| fibroblast | 15 studies | 25% ± 13% | |
| endothelial cell of artery | 12 studies | 47% ± 26% | |
| vein endothelial cell | 11 studies | 43% ± 18% | |
| endothelial cell of vascular tree | 11 studies | 39% ± 17% | |
| endothelial cell of lymphatic vessel | 8 studies | 25% ± 5% | |
| hematopoietic stem cell | 7 studies | 47% ± 16% | |
| hematopoietic precursor cell | 4 studies | 37% ± 13% | |
| glomerular endothelial cell | 4 studies | 58% ± 2% | |
| pericyte | 4 studies | 50% ± 31% | |
| pro-B cell | 4 studies | 29% ± 4% | |
| adventitial cell | 4 studies | 32% ± 4% | |
| mesothelial cell | 3 studies | 25% ± 5% |
Insufficient scRNA-seq data for expression of CD34 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 13289.06 | 652 / 653 | 98% | 32.22 | 593 / 605 |
| breast | 100% | 18621.68 | 458 / 459 | 98% | 26.85 | 1092 / 1118 |
| lung | 95% | 8894.42 | 550 / 578 | 91% | 15.02 | 1052 / 1155 |
| prostate | 95% | 5792.07 | 233 / 245 | 91% | 13.64 | 457 / 502 |
| bladder | 100% | 10973.14 | 21 / 21 | 85% | 11.87 | 427 / 504 |
| adrenal gland | 90% | 4057.22 | 233 / 258 | 92% | 26.94 | 212 / 230 |
| intestine | 94% | 7048.47 | 906 / 966 | 85% | 12.80 | 448 / 527 |
| esophagus | 89% | 10897.46 | 1291 / 1445 | 86% | 13.70 | 158 / 183 |
| kidney | 92% | 6505.21 | 82 / 89 | 83% | 60.89 | 751 / 901 |
| uterus | 99% | 13240.78 | 169 / 170 | 74% | 11.39 | 339 / 459 |
| ovary | 81% | 5042.38 | 145 / 180 | 84% | 10.37 | 363 / 430 |
| stomach | 74% | 4083.00 | 265 / 359 | 91% | 16.53 | 259 / 286 |
| skin | 70% | 5869.27 | 1262 / 1809 | 88% | 14.73 | 413 / 472 |
| brain | 34% | 1090.29 | 901 / 2642 | 91% | 13.59 | 644 / 705 |
| pancreas | 27% | 773.46 | 87 / 328 | 97% | 22.36 | 172 / 178 |
| adipose | 100% | 28219.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.48 | 1 / 1 |
| heart | 100% | 13254.01 | 858 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 91% | 8139.76 | 1218 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 88% | 4066.62 | 703 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 87% | 13.61 | 353 / 406 |
| spleen | 83% | 2899.14 | 200 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 8.11 | 24 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 8.84 | 36 / 45 |
| eye | 0% | 0 | 0 / 0 | 33% | 2.43 | 26 / 80 |
| peripheral blood | 0% | 14.99 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048870 | Biological process | cell motility |
| GO_0071971 | Biological process | extracellular exosome assembly |
| GO_0030097 | Biological process | hemopoiesis |
| GO_0032703 | Biological process | negative regulation of interleukin-2 production |
| GO_0003094 | Biological process | glomerular filtration |
| GO_0010629 | Biological process | negative regulation of gene expression |
| GO_0042482 | Biological process | positive regulation of odontogenesis |
| GO_0045766 | Biological process | positive regulation of angiogenesis |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0007165 | Biological process | signal transduction |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0038001 | Biological process | paracrine signaling |
| GO_0072011 | Biological process | glomerular endothelium development |
| GO_0071425 | Biological process | hematopoietic stem cell proliferation |
| GO_0035759 | Biological process | mesangial cell-matrix adhesion |
| GO_0050900 | Biological process | leukocyte migration |
| GO_0001935 | Biological process | endothelial cell proliferation |
| GO_0072254 | Biological process | metanephric glomerular mesangial cell differentiation |
| GO_0003158 | Biological process | endothelium development |
| GO_2001214 | Biological process | positive regulation of vasculogenesis |
| GO_0071657 | Biological process | positive regulation of granulocyte colony-stimulating factor production |
| GO_0061042 | Biological process | vascular wound healing |
| GO_0001894 | Biological process | tissue homeostasis |
| GO_0060290 | Biological process | transdifferentiation |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0072089 | Biological process | stem cell proliferation |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005764 | Cellular component | lysosome |
| GO_0009925 | Cellular component | basal plasma membrane |
| GO_0045171 | Cellular component | intercellular bridge |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0036053 | Cellular component | glomerular endothelium fenestra |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0043199 | Molecular function | sulfate binding |
| Gene name | CD34 |
| Protein name | CD34 antigen Hematopoietic progenital cell antigen CD34 CD34 molecule Hematopoietic progenitor cell antigen CD34 Hematopoietic progenitor cell antigen CD34 (CD antigen CD34) |
| Synonyms | |
| Description | FUNCTION: Possible adhesion molecule with a role in early hematopoiesis by mediating the attachment of stem cells to the bone marrow extracellular matrix or directly to stromal cells. Could act as a scaffold for the attachment of lineage specific glycans, allowing stem cells to bind to lectins expressed by stromal cells or other marrow components. Presents carbohydrate ligands to selectins. |
| Accessions | ENST00000367036.7 Q8IUM0 ENST00000356522.4 [P28906-2] Q3C1E7 ENST00000310833.12 [P28906-1] Q5JTA5 P28906 Q9UH97 |